Mild COVID Not Linked to Long-Term Cardiac Damage
Prospective study shows no evidence of myocarditis
Stay updated with breaking news from James Moon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prospective study shows no evidence of myocarditis
Researchers have developed a nanoparticle that can deliver cancer immunotherapy intravenously. It could open new doors for fighting tumors.
Cancer immunotherapy seeks to turn "cold" tumors into "hot" tumors––those that respond to immunotherapy––by awakening and enlisting the body's own immune system.
Researchers report they have developed nanoparticles to deliver STING agonists and metal ions for intravenous cancer immunotherapy.
Cancer immunotherapy aims to change “cold” tumors into “hot” tumors – those that react to immunotherapy – by stimulating and enlisting the immune system of the body.